BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2463754)

  • 1. Management of patients with low-grade follicular lymphoma.
    Cabanillas FF
    Am J Clin Oncol; 1989 Feb; 12(1):81-7. PubMed ID: 2463754
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular response of follicular lymphoma to cyclophosphamide, doxorubicin, vincristine, prednisone C(H)OP or COP-based therapy as measured by polymerase chain reaction evidence of translocation (14;18)(q32;q21).
    Ha CS; Lee MS; McLaughlin P; Tucker SL; Wilder RB; Cox JD; Cabanillas F
    Cancer J; 2004; 10(1):49-53. PubMed ID: 15000495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Something old, something few, something subjective, something déjà vu.
    Horning SJ
    J Clin Oncol; 2003 Jan; 21(1):1-2. PubMed ID: 12506161
    [No Abstract]   [Full Text] [Related]  

  • 4. Presence of t(14;18) positive cells in blood and bone marrow does not predict outcome in follicular lymphoma.
    Paszkiewicz-Kozik E; Kulik J; Fabisiewicz A; Tysarowski A; Kraszewska E; Siedlecki JA; Walewski J
    Med Oncol; 2009; 26(1):16-21. PubMed ID: 18470485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
    Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P
    J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition?
    Northup JK; Gadre SA; Ge Y; Lockhart LH; Velagaleti GV
    Eur J Haematol; 2007 Feb; 78(2):152-6. PubMed ID: 17313561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One single dose of rituximab added to a standard regimen of CHOP in primary treatment of follicular lymphoma appears to result in a high clearance rate from circulating bcl-2/IgH positive cells: Is the end of molecular monitoring near?
    Schmitt C; Grundt A; Buchholtz C; Scheuer L; Benner A; Hensel M; Ho AD; Leo E
    Leuk Res; 2006 Dec; 30(12):1563-8. PubMed ID: 16530831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histiocytic sarcoma progressing from follicular lymphoma and mimicking acquired hemophagocytic lymphohistiocytosis.
    Schünemann C; Göhring G; Behrens YL; Kreipe HH; Ganser A; Thol F
    Ann Hematol; 2020 Oct; 99(10):2441-2443. PubMed ID: 32808104
    [No Abstract]   [Full Text] [Related]  

  • 9. Hematology: Follicular lymphoma: maintenance therapy is (often) indicated.
    Seymour JF
    Nat Rev Clin Oncol; 2009 Nov; 6(11):624-6. PubMed ID: 19861993
    [No Abstract]   [Full Text] [Related]  

  • 10. LightCycler-based quantitative real-time PCR monitoring of patients with follicular lymphoma receiving rituximab in combination with conventional or high-dose cytotoxic chemotherapy.
    Martin S; Fischer C; Free M; Kurreck B; Stockinger H; Fenk R; Arnold C; Kliszewski S; Meckenstock G; Haas R; Kronenwett R
    Eur J Haematol; 2005 Apr; 74(4):282-92. PubMed ID: 15777339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
    Colombat P; Cornillet P; Deconinck E; Tourani JM; Gardembas M; Delain M; Abgrall JF; Kootz C; Milpied N
    Bone Marrow Transplant; 2000 Nov; 26(9):971-7. PubMed ID: 11100276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Follicular lymphomas. Therapeutic indications].
    Solal-Céligny P
    Presse Med; 1992 Apr; 21(14):649-51. PubMed ID: 1534616
    [No Abstract]   [Full Text] [Related]  

  • 13. Homonymous hemianopsia in a patient with Hodgkin's lymphoma in remission after BEACOPP chemotherapy.
    Bruessow C; Karrer U; Gubler J; Pless M
    J Clin Oncol; 2012 Apr; 30(12):e130-2. PubMed ID: 22393099
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined modality treatment in stage I and II diffuse non-Hodgkin's lymphomas.
    Bonadonna G; Valagussa P; Buzzoni R; Bajetta E
    Prog Clin Biol Res; 1985; 201():369-74. PubMed ID: 2419921
    [No Abstract]   [Full Text] [Related]  

  • 15. Follicular lymphoma: 2012 update on diagnosis and management.
    Freedman A
    Am J Hematol; 2012 Oct; 87(10):988-95. PubMed ID: 23001911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningeal relapse by follicular lymphoma as a single mass.
    Moreno García V; Redondo A; Fernández Zubillaga A; González-Barón M
    Clin Transl Oncol; 2008 Mar; 10(3):180-1. PubMed ID: 18321822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of bone marrow lymphoid infiltrates after immunochemotherapy for follicular lymphoma.
    Laurent C; de Paiva GR; Ysebaert L; Laurent G; March M; Delsol G; Brousset P
    Am J Clin Pathol; 2007 Dec; 128(6):974-80. PubMed ID: 18024323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid cytogenetics of chronic lymphocytic leukemia and follicular cell lymphoma in a case of non-Hodgkin's lymphoma.
    Babu Rao V; Kerketta L; Madkaikar M; Farah J; Ghosh K
    Acta Haematol; 2006; 116(2):150-2. PubMed ID: 16914914
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of diffuse large B-cell lymphosarcoma with involvement of bone marrow in an old female patient].
    Zamiatina VI; Kravchenko SK; Giliazitdinova EA; Magomedova AU; Vorob'ev IA; Gotman LN; Kaplanskaia IB; Kesel'man SA; Obukhova TN; Sakhibov IaD; Shevelev AA; Kremenetskaia AM
    Ter Arkh; 2008; 80(7):54-7. PubMed ID: 18763597
    [No Abstract]   [Full Text] [Related]  

  • 20. Ten years' experience with four cycles of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, procarbazine (BEACOPP)-escalated followed by four cycles of baseline-dose BEACOPP in patients with advanced stage Hodgkin lymphoma: a single-center, retrospective study.
    Belada D; Štěpánková P; Sýkorová A; Žák P; Smolej L
    Leuk Lymphoma; 2015 Jul; 56(7):2013-8. PubMed ID: 25330440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.